| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Cohen Yuval is a Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2015 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Executive Officer | Buy | 535 | $1.76 | $941.23 | +8.5% | |
| Nov 13, 2015 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Executive Officer | Buy | 850 | $1.73 | $1,470.50 | +15.6% | |
| Aug 24, 2015 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Executive Officer | Buy | 550 | $1.95 | $1,070.41 | +11.2% | |
| Aug 17, 2015 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Executive Officer | Buy | 2,100 | $1.92 | $4,027.93 | +31.7% | |
| Jun 15, 2015 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Executive Officer | Buy | 900 | $3.28 | $2,952.00 | +47.4% |